NCT03635983 2025-04-01A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic MelanomaBristol-Myers SquibbPhase 3 Completed783 enrolled 24 charts